DK123355B - Analogifremgangsmåde til fremstilling af 9-xantenylurinstofderivater. - Google Patents
Analogifremgangsmåde til fremstilling af 9-xantenylurinstofderivater.Info
- Publication number
- DK123355B DK123355B DK440567AA DK440567A DK123355B DK 123355 B DK123355 B DK 123355B DK 440567A A DK440567A A DK 440567AA DK 440567 A DK440567 A DK 440567A DK 123355 B DK123355 B DK 123355B
- Authority
- DK
- Denmark
- Prior art keywords
- xanthenylurea
- derivatives
- preparation
- analogous process
- analogous
- Prior art date
Links
- WEDNBKOVRBVKBV-UHFFFAOYSA-N 9h-xanthen-9-ylurea Chemical class C1=CC=C2C(NC(=O)N)C3=CC=CC=C3OC2=C1 WEDNBKOVRBVKBV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D311/88—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
- C07D335/12—Thioxanthenes
- C07D335/14—Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D335/18—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Multimedia (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB05692/67A GB1181673A (en) | 1966-09-02 | 1966-09-02 | Derivatives of Xanthen and Thiaxanthen and Preparation Thereof |
| NL6711975A NL150793B (nl) | 1966-09-02 | 1967-08-31 | Werkwijze voor het bereiden van een geneesmiddel met een werking tegen zweren en onder toetoepassing van deze werkwijze verkregen gevormde geneesmiddelen, alsmede werkwijze voor het bereiden van hiervoor geschikte geneeskrachtige xantheen- of thioxantheenderivaten. |
| US00352504A US3855406A (en) | 1966-09-02 | 1973-04-19 | Thiaxanthene derivatives useful for treating peptic ulcers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK123355B true DK123355B (da) | 1972-06-12 |
Family
ID=27257289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK440567AA DK123355B (da) | 1967-04-05 | 1967-09-01 | Analogifremgangsmåde til fremstilling af 9-xantenylurinstofderivater. |
Country Status (3)
| Country | Link |
|---|---|
| AT (1) | AT296328B (da) |
| DK (1) | DK123355B (da) |
| SE (2) | SE311024B (da) |
-
1962
- 1962-10-23 SE SE11350/62A patent/SE311024B/xx unknown
-
1967
- 1967-09-01 DK DK440567AA patent/DK123355B/da unknown
- 1967-09-01 AT AT249371A patent/AT296328B/de not_active IP Right Cessation
- 1967-09-01 SE SE12168/67A patent/SE349028B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE349028B (da) | 1972-09-18 |
| SE311024B (da) | 1969-05-27 |
| AT296328B (de) | 1972-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK137232B (da) | Analogifremgangsmåde til fremstilling af phenylethanolaminer. | |
| DK122222B (da) | Fremgangsmåde til fremstilling af alk-3-en-1-oler. | |
| DK120698B (da) | Analogifremgangsmåde til fremstilling af acetylguanidiner. | |
| DK133783B (da) | Fremgangsmåde til fremstilling af 7-halogen-7-desoxy-1-thio-alfa-D-galacto-octopyranosider. | |
| DK124080B (da) | Fremgangsmåde til fremstilling af D-6-metyl-8-cyanmetylergolin. | |
| DK124756B (da) | Analogifremgangsmåde til fremstilling af piperazinderivater. | |
| DK118820B (da) | Analogifremgangsmåde til fremstilling af derivater af 5-nitro-2-furyl-isoxazoliner. | |
| DK135281B (da) | Analogifremgangsmåde til fremstilling af derivater af L-hydroxyprolin. | |
| DK123942C (da) | Analogifremgangsmåde til fremstilling af benzothiazepinderivater. | |
| DK119307B (da) | Fremgangsmåde til fremstilling af ketonitriler. | |
| DK123868B (da) | Analogifremgangsmåde til fremstilling af 3-hydroxycumarin-derivater. | |
| DK122758B (da) | Fremgangsmåde til fremstilling af α-methyl-multicyclo-methylaminer. | |
| DK115766B (da) | Analogifremgangsmåde til fremstilling af thiocarbamidderivater. | |
| DK118507B (da) | Fremgangsmåde til fremstilling af 3-dimethylsulfamoylphenthiazinderivater. | |
| DK123100B (da) | Fremgangsmåde til fremstilling af N-tritylimidazoler. | |
| DK122522B (da) | Fremgangsmåde til fremstilling af dichlorquinoliner. | |
| DK124214B (da) | Fremgangsmåde til fremstilling af pyrrolnitrinderivater. | |
| DK119663B (da) | Analogifremgangsmåde til fremstilling af 2-benzolsulfonamidopyrimidinforbindelser. | |
| DK123721B (da) | Analogifremgangsmåde til fremstilling af pyrazinderivater. | |
| DK120598B (da) | Analogifremgangsmåde til fremstilling af furazanderivater. | |
| DK125285B (da) | Analogifremgangsmåde til fremstilling af furazanderivater. | |
| DK119976B (da) | Analogifremgangsmåde til fremstilling af 18-methyl-19-nor-17α-hydroxyprogesteroner og -17-estere deraf. | |
| DK118291B (da) | Analogifremgangsmåde til fremstilling af 10α-alkoxy-9,10-dihydroergolinderivater. | |
| DK118287B (da) | Fremgangsmåde til fremstilling af indolderivater. | |
| DK122666B (da) | Analogifremgangsmåde til fremstilling af hydrocortison-17-cyclopentancorboxylat. |